Skip to main content

Table 3 TLR%, CD14/TLR4, TLR_MFI, IL6 and TREM1 data

From: Role of dexmedetomidine in modifying immune paralysis in patients with septic shock: randomized controlled trial

 

Group D (n = 12)

Median (IQR)

Group M (n = 12)

Median (IQR)

P value

ANOVA

P value

TLR% 0

3.9 (2.85–13.75)

7.95 (3.2–12.5)

0.88

0.59

TLR% 12H

3.7 (1.7–14.42)

4.6 (2.87–8.12)

0.54

 

TLR% 24H

3 (1.5–6.42)

3.6 (2.3–4.22)

0.26

 

CD14/TLR4% 0

1.7 (1.2–7.22)

1.85 (0.4–3.6)

0.25

0.3

CD14/TLR4% 12H

1.8 (0.7–4.8)

1.7 (0.9–2.92)

0.45

 

CD14/TLR4% 24H

0.95 (0.62–3.52)

1.45 (0.65–2.4)

0.5

 

TLR-MFI 0

2998 (1053–6564.5)

1517 (951.3–4235.7)

0.2

0.67

TLR-MFI 12H

2163.5 (956.7–3637.25)

2068.5 (992–3043.25)

0.22

 

TLR-MFI 24H

2011 (1433.75–5072.75)

2483 (1306.75–8458.7)

0.52

 

IL6 0 (pg/mL)

351.4 (215.2–1012.3)

318.1 (131.2–1405.2)

0.84

0.74

IL6 12H (pg/mL)

97.6 (46.7–263.2)

185.8 (72.7–329.3)

0.39

 

IL6 24H (pg/mL)

80.5 (37.1–135.6)

71 (51.8–163.7)

0.53

 

TREM1 0 (pg/mL)

609.34 (248.9–1113.5)

653.6 (334–943.7)

0.97

0.18

TREM1 12H (pg/mL)

745.1 (318.3–875.5)

373.4 (220.75–782)

0.11

 

TREM1 24H (pg/mL)

532.4 (240.6–1083.2)

442.3 (119.1–618.3)

0.12

 
  1. Data are presented as the median (interquartile range)
  2. TLR Toll-like receptors, MFI Mean fluorescent intensity, IL Interleukin, TREM1 Triggering receptor expressed on myeloid cells